Royalty Rate Report Promo




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Royalty Rate Report Promo
Released on: May 22, 2012. © PharmaTelevision Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    This Report is the pharmaceutical and biotech industry’s standard reference work on royalty rates, published annually by PharmaVentures, the experts in deals and alliances, now online and fully interactive.
  • Summary
  • Transcript
  • Participants
  • Company
This Report is the pharmaceutical and biotech industry’s standard reference work on royalty rates, published annually by PharmaVentures, the experts in deals and alliances, now online and fully interactive. The 2012 Report presents major new case studies, and provides full, new data and analysis based on data from the premier agreements database, PharmaDeals v4, and other sources. Topics include Royalties and Deal Structures, Sales Milestones, Tiered Royalties, Alternative Structures, Technology Deals, Deal Creativity, Upfront Payments and Milestones, Royalties and IP Values and Market Cap, and Royalty Rates by Phase and Indication.

Full details available on the PharmaDeals website.
Nigel Borshell, BSc. (Director)
Nigel has over 30 years experience in Life Sciences including senior international commercial management roles in diagnostics and biotechnology gained at drug testing specialists Syva Company, Hoechst’s Behring division, US diagnostics giant Dade Behring, and as European Business Development Director for California-based Cepheid. Nigel is the author of numerous Pharmaceutical/Biotech Industry reports, papers and articles. At PharmaVentures, Nigel specialises in valuation methodologies, deal structure modelling, and pricing policies.

Heather Cartwright MBiochem, DipFM (Associate Senior Advisor)
Heather is an experienced advisor with particular expertise in forecasting and product valuation, competitive landscaping, market analysis and transfer pricing. She has also delivered workshops on valuation methodologies. Her current focus at PharmaVentures is on providing expert opinion on the structure and pricing of pharmaceutical licensing transactions. Prior to joining PharmaVentures, Heather gained her undergraduate degree in Molecular and Cellular Biochemistry from Trinity College, University of Oxford and she has since been awarded the ACCA Diploma in Financial Management.
Nigel Borshell, BSc. (Director)
Nigel has over 30 years experience in Life Sciences including senior international commercial management roles in diagnostics and biotechnology gained at drug testing specialists Syva Company, Hoechst’s Behring division, US diagnostics giant Dade Behring, and as European Business Development Director for California-based Cepheid. Nigel is the author of numerous Pharmaceutical/Biotech Industry reports, papers and articles. At PharmaVentures, Nigel specialises in valuation methodologies, deal structure modelling, and pricing policies.

Heather Cartwright MBiochem, DipFM (Associate Senior Advisor)
Heather is an experienced advisor with particular expertise in forecasting and product valuation, competitive landscaping, market analysis and transfer pricing. She has also delivered workshops on valuation methodologies. Her current focus at PharmaVentures is on providing expert opinion on the structure and pricing of pharmaceutical licensing transactions. Prior to joining PharmaVentures, Heather gained her undergraduate degree in Molecular and Cellular Biochemistry from Trinity College, University of Oxford and she has since been awarded the ACCA Diploma in Financial Management.
Pharmadeals
PharmaDeals is the publishing division of PharmaVentures. Whether you require data for benchmarking, competition analysis or simply to find out what new intellectual properties are being licensed, PharmaDeals gives you access to the latest deal making information in the pharmaceutical and biotech field. Intelligently indexed, the new PharmaDeals v4 database is the ultimate benchmarking tool. PharmaDeals also publishes a range of industry-leading reports, as well as PharmaDeals Review, the online serial with industry insight and analysis.